Stockreport

Revamping best-selling drugs to combat patent cliff has limits [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Patent expiry is a phenomenon that haunts every pharmaceutical company, with the loss of market exclusivity often causing a dramatic dip in a company's profits. This ca [Read more]